Quantcast
Scientists Sleuth Out Proteins Involved In Crohns Disease

Scientists Sleuth Out Proteins Involved In Crohn's Disease

Tracey Bryant, University of Delaware University of Delaware researchers have identified a protein, hiding in plain sight, that acts like a bodyguard to help protect and stabilize another key protein, that when unstable, is involved in...

Latest Immunology Stories

2014-07-22 12:27:43

Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass., July 22, 2014 /PRNewswire/ -- Decision Resources Group finds that over half of audited multiple sclerosis (MS) patients currently treated with Biogen Idec's oral disease-modify therapy (DMT) Tecfidera have ever experienced flushing and/or gastrointestinal events while on the therapy. However, few...

2014-07-18 23:02:00

Annual conference provides groundbreaking approaches to treating patients with interrelated autoimmune conditions. Malvern, PA (PRWEB) July 18, 2014 The inaugural Interdisciplinary Autoimmune Summit (IAS) brought together more than 150 gastroenterologists, rheumatologists, dermatologists, immunologists, internists, industry, and other allied healthcare professionals at The Mirage, Las Vegas, NV, June 20-22, 2014. "IAS 2014 was a wonderful opportunity to meet and discuss best...

2014-07-18 16:20:57

Gase's racecar will feature Dylan Richardson, a seven-year-old donor who saved three lives through donation CENTENNIAL, Colo., July 18, 2014 /PRNewswire-USNewswire/ --AlloSource, one of the nation's largest providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, is sponsoring Joey Gase, a NASCAR Nationwide Series Driver and donor son, in the NASCAR Nationwide Series EnjoyIllinois.com 300 race at...

2014-07-16 12:39:43

Johns Hopkins Medicine Process suggests a new type of immunotherapy A team of researchers has devised a Pac-Man-style power pellet that gets normally mild-mannered cells to gobble up their undesirable neighbors. The development may point the way to therapies that enlist patients' own cells to better fend off infection and even cancer, the researchers say. A description of the work will be published July 15 in the journal Science Signaling. "Our goal is to build artificial cells...

2014-07-16 08:29:40

HERZLIYA, Israel, July 16, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, announced today that an overview of its hCDR1 peptide to treat patients with systemic lupus erythematosus (SLE) is included in an article titled, Novel Approaches to the Development of...

2014-07-16 08:28:09

--Novel Biologic Targets Innovative New Mechanism in Lupus-- SEATTLE, July 16, 2014 /PRNewswire/ -- Resolve Therapeutics, LLC announced today the initiation of a multi-dose, one month phase 2 clinical study with its lead compound RSLV-132 in systemic lupus erythematosus (SLE). http://photos.prnewswire.com/prnvar/20140715/127341 Following the successful completion of it phase 1 single dose safety study with RSLV-132, Resolve recently initiated a phase 2 study in lupus patients. The...

2014-07-16 08:27:11

OXFORD, England and INDIANAPOLIS, July 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Immunocore Limited today announced they have entered into a co-discovery and co-development collaboration to research and potentially develop novel T cell-based cancer therapies. Using Immunocore's Immune Mobilising Monoclonal T-Cell Receptor Against Cancer (ImmTAC) technology, the companies will seek to use the power of the body's own immune system to attack cancer cells. ImmTACs...

2014-07-16 04:21:39

TUEBINGEN, Germany, July 16, 2014 /PRNewswire/ -- Funds will be used to complete phase 3 study with IMA901 and to invest in the expansion of immatics' Human Immunopeptidome Program to identify the most relevant targets for cancer immunotherapies immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company leading the development of advanced immunotherapies that are active against cancer, today announces that it has...

2014-07-15 08:28:23

MONROVIA, Calif., July 15, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced the appointment of Kurt Gustafson to its board of directors. Mr. Gustafson will also serve as chair of Xencor's audit committee and as a member of the compensation committee. Xencor also announced the promotion of John R....

2014-07-14 12:27:15

Special happenings at this year's event: liver recipient meets her donor's family for the first time, baseball legend Vinny Castilla hosts children's area DENVER, July 14, 2014 /PRNewswire/ -- One of Denver's most celebrated and attended cause-related 5Ks, the Donor Dash, is celebrating 15 years this summer. Taking place July 20 in Denver's historic Washington Park, the Donor Dash is a run/walk to honor the lives of organ, eye and tissue donors, celebrate the lives of recipients and...


Latest Immunology Reference Libraries

Thymus
2013-03-04 12:56:08

The thymus gland is an endocrine organ of the immune system located anteriolateral to the trachea and in between the lungs. Its primary function is to build T lymphocytes for the body’s immune system; therefore, it is most important during childhood and puberty, when it reaches its maximum size. After puberty, it will begin to atrophy and shrink in size. Old age generally brings about hypotrophy of the thymus. In children the thymus is grayish-pink in color and in adults it is yellow. On...

Journal of Allergy and Clinical Immunology
2012-05-14 11:51:18

The Journal of Allergy and Clinical Immunology is a medical journal established in 1929 as the Journal of Allergy. It is published by Elsevier. It obtained its current name in 1971. It is the official journal of the American Academy of Allergy, Asthma and Immunology. This journal publishes timely clinical papers, instructive case reports, and detailed examinations of state-of-the-art equipment and techniques to clinical allergists, immunologists, dermatologists, internists, and other...

0_e5a6bf87cbe21562e090f06b40e18885
2011-04-15 14:14:43

Clostridium tetani is a rod-shaped, anaerobic bacterium of the genus Clostridium. It's a gram-positive and resembles tennis rackets or drumsticks on a gram stain. It can be found as spores in soil and the gastrointestinal tract of animals. It produces a potent biological toxin which is the causative agent of tetanus. Ancient people recognized the relationship between wounds and fatal muscle spasms. Arthur Nicolaier isolated tetanus from soil bacteria. Antonie Carl and Giorgio Rattone...

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (4 articles) »
Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related